Home | Business News | CBJ Newsmakers | CCAB announces creation of new brain cancer therapeutic company, Empirica Therapeutics, as part of its strategy to advance new early-stage life sciences companies CCAB announces creation of new brain cancer therapeutic company, Empirica Therapeutics, as part of its strategy to advance new early-stage life sciences companies RecommendedFlightHub Group Welcomes The National Circus School To Its First Class Partnership ProgramINVENTURE$ 2023 draws to a close with record numbers in attendanceLargest Estuary Restoration Project on Vancouver Island starts work to revitalize crucial estuarine habitat
